Wisconsin man died after asthma inhaler cost skyrocketed to $539, lawsuit says
The parents of Cole Schmidtknecht, 22, are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the Wisconsin man's death in 2024.
Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
Capital Public Radio17h
Top California Democrats clash over how to rein in drug industry middlemen
California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...
HealthLeaders Media1d
Top CA Dems Clash Over How to Rein In PBMs
As prescription drug prices continue to spiral and federal efforts to control them stall, state lawmakers are focusing on ...
California bill targets drug industry middlemen, setting stage for fight over health costs
California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But lawmakers and the second-term governor are at odds over what to do about it, ...
Man dies of asthma attack after inhaler cost skyrockets to more than $500
United Health Group’s pharmacy benefit manager, Optum Rx, stopped covering Cole Schmidtknecht’s ‘life-changing’ inhaler, suit ...
Express Scripts, OptumRx Opioid Suit From Boston Ruled Untimely
Boston’s bid to hold two pharmacy benefit managers legally accountable for their alleged roles in the opioid epidemic under RICO and public nuisance claims was dismissed by a federal judge because it ...
The Independent6d
Grieving parents couldn’t understand how their son died of an asthma attack. Then they found out how much his meds now cost
The couple made headlines across America this week after they went public with a lawsuit against Walgreens and pharmacy benefits management company OptumRx, a subsidiary of United Health Group.
Health companies return $2.6 trillion to shareholders over time amid rising medical costs
Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...